Rouprêt M - Search Results

1

Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.

Wirth GJ, Haitel A, Moschini M, Soria F, Klatte T, Hassler MR, Bensalah K, Briganti A, Karam JA, Lotan Y, Margulis V, Raman JD, Remzi M, Rioux-Leclercq N, Robinson BD, Rouprêt M, Wood CG, Shariat SF. Wirth GJ, et al. Among authors: roupret m. World J Urol. 2017 Jun;35(6):943-949. doi: 10.1007/s00345-016-1946-8. Epub 2016 Oct 11. World J Urol. 2017. PMID: 27730305

2

Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma?

Méjean A, Rouprêt M, Larousserie F, Hopirtean V, Thiounn N, Dufour B. Méjean A, et al. Among authors: roupret m. J Urol. 2003 Apr;169(4):1287-90. doi: 10.1097/01.ju.0000050221.51509.f5. J Urol. 2003. PMID: 12629344

3

Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience.

Roupret M, Hopirtean V, Mejean A, Thiounn N, Dufour B, Chretien Y, Chauveau D, Richard S. Roupret M, et al. J Urol. 2003 Nov;170(5):1752-5. doi: 10.1097/01.ju.0000092780.85876.de. J Urol. 2003. PMID: 14532769

4

Microsatellite instability as predictor of survival in patients with invasive upper urinary tract transitional cell carcinoma.

Rouprêt M, Fromont G, Azzouzi AR, Catto JW, Vallancien G, Hamdy FC, Cussenot O. Rouprêt M, et al. Urology. 2005 Jun;65(6):1233-7. doi: 10.1016/j.urology.2005.01.019. Urology. 2005. PMID: 15922421

5

Tissue microarray analysis of the prognostic value of E-cadherin, Ki67, p53, p27, survivin and MSH2 expression in upper urinary tract transitional cell carcinoma.

Fromont G, Rouprêt M, Amira N, Sibony M, Vallancien G, Validire P, Cussenot O. Fromont G, et al. Among authors: roupret m. Eur Urol. 2005 Nov;48(5):764-70. doi: 10.1016/j.eururo.2005.07.005. Epub 2005 Aug 1. Eur Urol. 2005. PMID: 16126329

6

Outcome after radical prostatectomy in young men with or without a family history of prostate cancer.

Rouprêt M, Fromont G, Bitker MO, Gattegno B, Vallancien G, Cussenot O. Rouprêt M, et al. Urology. 2006 May;67(5):1028-32. doi: 10.1016/j.urology.2005.11.035. Urology. 2006. PMID: 16698363

7

Comparison of open nephroureterectomy and ureteroscopic and percutaneous management of upper urinary tract transitional cell carcinoma.

Rouprêt M, Hupertan V, Traxer O, Loison G, Chartier-Kastler E, Conort P, Bitker MO, Gattegno B, Richard F, Cussenot O. Rouprêt M, et al. Urology. 2006 Jun;67(6):1181-7. doi: 10.1016/j.urology.2005.12.034. Urology. 2006. PMID: 16765178

8

Upper urinary tract transitional cell carcinoma: recurrence rate after percutaneous endoscopic resection.

Rouprêt M, Traxer O, Tligui M, Conort P, Chartier-Kastler E, Richard F, Cussenot O. Rouprêt M, et al. Eur Urol. 2007 Mar;51(3):709-13; discussion 714. doi: 10.1016/j.eururo.2006.07.019. Epub 2006 Jul 28. Eur Urol. 2007. PMID: 16911852

9

[Role of endoscopy in the management of upper urinary tract tumors].

Roupret M, Cussenot O, Chartier-Kastler E, Thibault P, Richard F, Conort P, Traxer O. Roupret M, et al. Prog Urol. 2006 Nov;16(5):537-41. Prog Urol. 2006. PMID: 17175946 Review. French.

10

Oncologic control after open or laparoscopic nephroureterectomy for upper urinary tract transitional cell carcinoma: a single center experience.

Rouprêt M, Hupertan V, Sanderson KM, Harmon JD, Cathelineau X, Barret E, Vallancien G, Rozet F. Rouprêt M, et al. Urology. 2007 Apr;69(4):656-61. doi: 10.1016/j.urology.2007.01.007. Urology. 2007. PMID: 17445646

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,065 results

Search Page

Filters